- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Trileptal ( Oxcarbazepine )
Trileptal (oxcarbazepine) is an anticonvulsant medication indicated for the treatment of partial-onset seizures in adults with epilepsy, either as monotherapy or adjunctive therapy. It is a 10-keto analogue of carbamazepine and works primarily by blocking voltage-sensitive sodium channels in neuronal membranes, thereby stabilizing hyperexcited nerve membranes, inhibiting repetitive neuronal firing, and reducing the propagation of synaptic impulses. Unlike carbamazepine, oxcarbazepine undergoes reductive metabolism to its active metabolite, licarbazepine (also known as monohydroxy derivative, MHD), which is largely responsible for its anticonvulsant activity and does not induce its own metabolism.
Usual adult dose: For monotherapy, the recommended initial dose is 300 mg twice daily (600 mg per day). The dose may be increased in 300 mg/day increments at weekly intervals to a maintenance dose of 600 mg twice daily (1200 mg per day). For adjunctive therapy, the recommended initial dose is 300 mg twice daily (600 mg per day). The dose may be increased in 600 mg/day increments at weekly intervals to a recommended maintenance dose of 600 mg twice daily (1200 mg per day). Doses up to 1200 mg twice daily (2400 mg per day) have been studied and may be effective in some patients; however, most patients cannot tolerate this dose due to central nervous system side effects. When converting from carbamazepine, the initial oxcarbazepine dose should be approximately 1.5 times the total daily carbamazepine dose, and gradual titration is recommended. Trileptal may be taken with or without food.
Dosage form: Film-coated tablets: 150 mg (pale grey-green, ovaloid, scored), 300 mg (yellow, ovaloid, scored), and 600 mg (light pink, ovaloid, scored). The scored tablets allow for flexible dosing and splitting where appropriate. An oral suspension (60 mg/mL) is also available for patients who have difficulty swallowing tablets.
Onset of action: Following oral administration, oxcarbazepine is rapidly absorbed and extensively converted to the active metabolite MHD. Peak plasma concentrations of MHD are reached within approximately 4 to 6 hours of a dose. Steady-state plasma concentrations are achieved within 2 to 3 days of twice-daily dosing. The therapeutic onset for seizure control is gradual and depends on dose titration; clinical benefit is typically assessed over several weeks of therapy at the target maintenance dose.
Duration of action: The elimination half-life of the active metabolite MHD is approximately 9 hours, allowing for twice-daily dosing with consistent 12-hour anticonvulsant coverage. The parent drug oxcarbazepine has a much shorter half-life of approximately 2 hours.
Alcohol recommendation: Alcohol consumption should be avoided during treatment with Trileptal. Alcohol may potentiate the central nervous system depressant effects of oxcarbazepine, including dizziness, drowsiness, impaired coordination, and decreased alertness. Concurrent use of alcohol and oxcarbazepine can significantly increase the risk of sedation and may reduce the seizure threshold, potentially compromising seizure control. Patients should not drive or operate machinery until they understand how the combination affects them.
Most common side effects: Dizziness, somnolence, headache, diplopia (double vision), blurred vision, nausea, vomiting, ataxia (impaired coordination), fatigue, and abnormal gait. Hyponatremia (serum sodium below 125 mmol/L) is a clinically important adverse effect, occurring in approximately 2.5% of treated patients; it is generally asymptomatic but may occasionally require dose adjustment or discontinuation. Most central nervous system side effects are dose-related and may be minimized by careful dose titration. Serious dermatological reactions, including Stevens-Johnson syndrome, have been reported rarely. Clinically significant hypersensitivity reactions occur less frequently with oxcarbazepine than with carbamazepine, although cross-sensitivity is observed in approximately 25% to 30% of patients.
Would you like to learn more about Trileptal (Oxcarbazepine) for the management of partial-onset seizures?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
